The NPC cells express the immune effector cell inhibiting programmed cell death ligand 1 (PD-L1) in about 85% of tumors [9], and tumor-infiltrating cytotoxic T‐lymphocytes (CTLs) show high expression of PD‐1 [10]. The gene discussed is PDCD1; the disease is nasopharyngeal carcinoma.